J&J Unit Hit With $5.6M Verdict Over Calif. Risperdal Death

Law360, Los Angeles (October 19, 2015, 10:40 PM EDT) -- A California jury on Friday hit Johnson & Johnson unit Janssen Pharmaceuticals with a $5.6 million verdict for the wrongful death of a man during a clinical study of the company's anti-psychotic medication Risperdal, after Janssen employees allegedly ignored abnormalities with his heart, his mother's attorneys announced Monday.

A Johnson & Johnson unit was ordered to pay $5.6 million over the death of a 25-year-old who died during a clinical study of Risperdal. (Credit: AP) Marion Liu, mother of Leo Liu, had alleged her then-25-year-old son, who suffered from schizophrenia, had enrolled in a human drug trial with Janseen, and died...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!